scholarly journals GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis

2018 ◽  
Vol 293 (11) ◽  
pp. 3949-3964 ◽  
Author(s):  
Keshuo Ding ◽  
Sheng Tan ◽  
Xing Huang ◽  
Xiaonan Wang ◽  
Xiaocan Li ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Tumor Growth ◽  
Cancer Patients ◽  
Survival Outcome ◽  
Poor Survival ◽  
Poor Survival Outcome ◽  
Tumor Growth And Metastasis ◽  
Gastric Cancer Patients

scholarly journals Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (12) ◽  
pp. 18848-18860 ◽  
Author(s):  
Shu Zhang ◽  
Shuling Huang ◽  
Chao Deng ◽  
Yu Cao ◽  
Jun Yang ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Patients ◽  
Survival Outcome ◽  
Poor Survival ◽  
Poor Survival Outcome ◽  
Gastric Cancer Patients

scholarly journals Low periostin expression predicts poor survival in intestinal type gastric cancer patients

2018 ◽  
Vol Volume 11 ◽  
pp. 25-36 ◽  
Author(s):  
Teming Zhang ◽  
Zheng Han ◽  
Arvine Chandoo ◽  
Xincheng Huang ◽  
Xiangwei Sun ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Patients ◽  
Intestinal Type ◽  
Poor Survival ◽  
Gastric Cancer Patients

Low Serum Albumin Correlates with Poor Survival in Gastric Cancer Patients

2018 ◽  
Vol 64 (03/2018) ◽  
Author(s):  
Xiaojuan Ouyang ◽  
Yuan Dang ◽  
Fan Zhang ◽  
Qiaojia Huang
Keyword(s):  
Gastric Cancer ◽  
Serum Albumin ◽  
Cancer Patients ◽  
Poor Survival ◽  
Gastric Cancer Patients ◽  
Low Serum

scholarly journals Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

2015 ◽  
Vol 21 (15) ◽  
pp. 3492-3500 ◽  
Author(s):  
Ivette A.G. Deckers ◽  
Leo J. Schouten ◽  
Leander Van Neste ◽  
Iris J.H. van Vlodrop ◽  
Patricia M.M.B. Soetekouw ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Renal Cell Cancer ◽  
Promoter Methylation ◽  
Renal Cell ◽  
Clear Cell ◽  
Cell Cancer ◽  
Survival Outcome ◽  
Poor Survival ◽  
Poor Survival Outcome

HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome

2019 ◽  
Vol 84 ◽  
pp. 133-141 ◽  
Author(s):  
Guangfei Cui ◽  
Feng Cai ◽  
Zhanwei Ding ◽  
Ling Gao
Keyword(s):  
Gastric Cancer ◽  
Survival Outcome ◽  
Human Gastric Cancer ◽  
Poor Survival ◽  
Poor Survival Outcome
Sign in / Sign up

Export Citation Format

Share Document